Patents/Assignees

Janssen Vaccines & Prevention B.V.

18 patents in portfolio

US12577279utility2026
Influenza Virus Vaccines and Uses Thereof
0 cites
US12454554utility2025
Influenza Virus Vaccines and Uses Thereof
0 cites
US12331077utility2025
Stabilized Pre-fusion RSV F Proteins
0 cites
US12234264utility2025
Stabilized Soluble Pre-fusion RSV F Proteins
0 cites
US12054737utility2024
Potent and Short Promoter for Expression of Heterologous Genes
0 cites
US11998597utility2024
Vaccine Against RSV
0 cites
US11905314utility2024
Influenza Virus Vaccines and Uses Thereof
0 cites
US11896663utility2024
Immunodeficiency Virus Type 1 (HIV-1) Mutant Envelope Proteins
0 cites
US11872281utility2024
Adenovirus and Uses Thereof
0 cites
US11857619utility2024
Multimodal Chromatography Method for the Purification of HIV-1 Envelope Glycoprotein
0 cites
US11820796utility2023
Trimer Stabilizing HIV Envelope Protein Mutations
0 cites
US11801297utility2023
Vaccine Against RSV
0 cites
US11781155utility2023
Potent and Balanced Bidirectional Promoter
0 cites
US11759514utility2023
Stabilized Pre-fusion RSV F Proteins
0 cites
US11732010utility2023
Trimer Stabilizing HIV Envelope Protein Mutations
0 cites
US11713469utility2023
Recombinant Adenoviral Vector Expressing Zika Antigen with Improved Productivity
0 cites
US11603389utility2023
HIV Vaccine Formulation
0 cites
US11603390utility2023
Stabilized Filovirus Glycoprotein Trimers
0 cites